Quantitative MR imaging of targeted SPIO particles on the cell surface and comparison to flow cytometry

Magnetic Resonance Imaging

Volumn 28, Issue 4, 2010, Pages 599-606

  Peldschus, Kersten ^a   Schultze, Alexander ^a   Nollau, Peter ^a   Kaul, Michael ^a   Schumacher, Udo ^a   Wagener, Christoph ^a   Adam, Gerhard ^a   Ittrich, Harald ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Carcinoembryonic antigen; Flow cytometry; Magnetic resonance relaxometry; Superparamagnetic iron oxide particle

Indexed keywords

ANTIBODY CONJUGATE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; GLYCOPROTEIN; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY T84.1; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HT29; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; CELL MEMBRANE; CONTRAST MEDIA; FERROSOFERRIC OXIDE; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; HYDRAZINES; MAGNETIC RESONANCE IMAGING; MICE;

ALEXA;

EID: 77952291155     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2009.12.017     Document Type: Article

References (29)

1. Rudin M., Rausch M., Stoeckli M. Molecular imaging in drug discovery and development: potential and limitations of nonnunclear methods. Magnetic resonance imaging with targeted contrast agents. Mol Imaging Biol 2005, 7(1):5-13.
2. Zhang C., Jugold M., Woenne E.C., Lammers T., Morgenstern B., Mueller M.M., et al. Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner. Cancer Res 2007, 67(4):1555-1562.
3. Reynolds P.R., Larkman D.J., Haskard D.O., Hajnal J.V., Kennea N.L., George A.J., et al. Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 2006, 241(2):469-476.
4. Montet X., Montet-Abou K., Reynolds F., Weissleder R., Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia 2006, 8(3):214-222.
5. Huh Y.M., Jun Y.W., Song H.T., Kim S., Choi J.S., Lee J.H., et al. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 2005, 127(35):12387-12391.
6. Kang H.W., Josephson L., Petrovsky A., Weissleder R., Bogdanov A. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconjug Chem 2002, 13(1):122-127.
7. Dahnke H., Schaeffter T. Limits of detection of SPIO at 3.0 T using T2 relaxometry. Magn Reson Med 2005, 53(5):1202-1206.
8. Gold P., Freedman S.O. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965, 122(3):467-481.
9. Hammarstrom S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 1999, 9(2):67-81.
10. Goldenberg D.M., Sharkey R.M., Paganelli G., Barbet J., Chatal J.F. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy. J Clin Oncol 2006, 24(5):823-834.
11. Venisnik K.M., Olafsen T., Gambhir S.S., Wu A.M. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging. Mol Imaging Biol 2007, 9(5):267-277.
12. Tiefenauer L.X., Tschirky A., Kühne G., Andres R.Y. In vivo evaluation of magnetite nanoparticles for use as a tumor contrast agent in MRI. Magn Reson Imaging 1996, 14(4):391-402.
13. Beauchemin N., Draber P., Dveksler G., Gold P., Gray-Owen S., Grunert F., et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp Cell Res 1999, 252(2):243-249.
14. Wagener C., Yang Y.H., Crawford F.G., Shively J.E. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies. J Immunol 1983, 130(5):2308-2315.
15. Wagener C., Clark B.R., Rickard K.J., Shively J.E. Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: determination of affinities and specificities of monoclonal antibodies by using biotin-labeled antibodies and avidin as precipitating agent in a solution phase immunoassay. J Immunol 1983, 130(5):2302-2307.
16. Bogoevska V., Horst A., Klampe B., Lucka L., Wagener C., Nollau P. CEACAM1, an adhesion molecule of human granulocytes, is fucosylated by fucosyltransferase IX and interacts with DC-SIGN of dendritic cells via Lewis x residues. Glycobiology 2006, 16(3):197-209.
17. Daldrup-Link H.E., Rudelius M., Piontek G., Metz S., Brauer R., Debus G., et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005, 234(1):197-205.
18. Wagner S., Schnorr J., Pilgrimm H., Hamm B., Taupitz M. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol 2002, 37(4):167-177.
19. Kuhlpeter R., Dahnke H., Matuszewski L., Persigehl T., von Wallbrunn A., Allkemper T., et al. mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing. Radiology 2007, 245(2):449-457.
20. Artemov D., Mori N., Okollie B., Bhujwalla Z.M. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003, 49(3):403-408.
21. Funovics M.A., Kapeller B., Hoeller C., Su H.S., Kunstfeld R., Puig S., et al. MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents. Magn Reson Imaging 2004, 22(6):843-850.
22. Zhu W., Okollie B., Bhujwalla Z.M., Artemov D. PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach. Magn Reson Med 2008, 59(4):679-685.
23. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13(1):95-99.
24. Geninatti Crich S., Bussolati B., Tei L., Grange C., Esposito G., Lanzardo S., et al. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. Cancer Res 2006, 66(18):9196-9201.
25. Medarova Z., Pham W., Kim Y., Dai G., Moore A. In vivo imaging of tumor response to therapy using a dual-modality imaging strategy. Int J Cancer 2006, 118(11):2796-2802.
26. Horst A.K., Ito W.D., Dabelstein J., Schumacher U., Sander H., Turbide C., et al. Carcinoembryonic antigen-related cell adhesion molecule 1 modulates vascular remodeling in vitro and in vivo. J Clin Invest 2006, 116(6):1596-1605.
27. Ergun S., Kilik N., Ziegeler G., Hansen A., Nollau P., Gotze J., et al. CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol Cell 2000, 5(2):311-320.
28. Peldschus K., Kaul M., Lange C., Nolte-Ernsting C., Adam G., Ittrich H. Magnetic resonance imaging of single SPIO labeled mesenchymal stem cells at 3 Tesla. Rofo 2007, 179(5):473-479.
29. Sun R., Dittrich J., Le-Huu M., Mueller M.M., Bedke J., Kartenbeck J., et al. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol 2005, 40(8):504-513.